REGISTERED COMPANY NUMBER: 00899518 (Enoland and Waleg) REGISTEREO CHARIfY NUMBEK. 261047 REPORT OF TNE TRUSTEES AND AUDrrED FINANCIAL ATEmENTs FOR THE YEAR ENDED 31 DECEMBER 20Z4 FOR LABOIIATORY ANIMALS LIMITED (A COMPANY LIMITED BY GUARArirEE) Hartley Fowler LLP statutory AuditOT5 Chartered Accauntants PavilK)n Vlew 19 New Road Brighton East Sussex BNI IEY
LABORATORY ANIMALS LIMrrED coKrEKfs OF THE FINANCIAL sfATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Pa Report of the Trwtee• I to 7 Report of the Independ•ntAudltor• 8 to 11 stthm•nt of Flnanclal Actlvltl•s 12 nc• Sheet 13 Nots• to the AnJn¢l•l Statements 14 to 20 Detailed Statsm•rt of Fln•ncthl Actlvltl•• 21 to 22
LABORATORY ANIMALS LIMITED (REGISTERED NUMBER: 00899518) REPORT OF THE TRusfEES FOR THE YEAR ENDED 310ECEMBER 2024 The trustees who are a150 d1CtorS of the tharlty for the purposes of the Companies kt 2006, present their re wth the finanoal statements of the charlty for the year ended 31 December 2024. The trutss have adopted provisths of kcounting and Reportjng by Charitles.. Statement of Recommended Prathtr appllcable to charitses preparing their accounts In accordance with the Financvdl Reporting Stsndard Jpplicable In the UK and Rewbllc of Irdond {FRS 102) (effectfve l January 2019). Thls rert akn wntslns the Ilrectors, reF¢)rt as requlred by company law. Labcntory Anlmals Llmlted Is a ccfflpany Ilrnlted by guarnntee and has no share capital. The cornpony was incorpjrated under the Ccfflpans Act 1948. Each memter has guaranteed to pay £5 in the event of windlng up the companv. oB]EIvEs AND ACTIVMES ObJectl¥es and alms The Memorandurn and Articles of Association obllges the company to aPY all it5 re50vrces to the advanrnt of public education in laboratory anlrnal xnce, tethno and weKare. The prindpal obJeLtlve5 01 the cornpany are to ach these alms by puPAlcalkin of the Joumal, "Laboratory Animals" ond by fundiryJ a range of initiatives In the rId ol ialKatory anlmal saence, especially focused on 'train the tralner. Inbtlatfves.
LABORATORY AN114ALS LIMITED (REGIsfERED NUMBER: 00899518) REPORT OF THE TRusfEES FOR THE YEAR ENDED JI DECEMBER 2024 Slgnlficart activities The prfndpal objectives of the company have been athEved In 2024 by publithing the journal 'Lab)r4tory Animals" {LA]I, and by Conn[ng to provide financial alSEnCe for workshops, training course5, conferences and for other Initlatlves that are relevant In the of Laboratory Anlmal Sdence, rnedicine, technoloyy and welfare. The Trustees (Council of Management, COMI held one face-ttrface meety.ng in June and a rtUal TTeUng in January.. a5 a cost savlng me3re it has been agreed to aim to hdd only one ra-t0•face meetlng annually, unless events require otherwise. The ExecutNe Committee IECI, which OVeee5 the ¢ky-to-day ¢Tation of the company, held one laCtfrface meettng in December, three virtual meetlngs In February, September and Ottober. LAL'S Annual Genernl Meetin9 was held virtualty Sn september. The Edltorhl Team Ild six meerS durlng 2024, one of whlch Induded Section Editors. The publlcauon frequency of the JcAwnal has condnued at 6 Issues o yeor, publlthed on-llne onty, as Inttuted In 2021. Individual arUcle5 a accessie through the SAGEILAJ webste, and a '11ippable", coveT-ttr(over format such that Its layout 6nd content are IdenCal to the paper k)umal, Is avalLable on the LAL weby'te. Thls Is accessIb to rnembers ol Subscribing Associaty"ons who subscrite to the journal usSng a secure username and password systern. The avall6bllity of thls forrnat has the advantage of brlnglng mre trafflc to the LAL EbsIte and Is also more attractNe ro advertlsers. Subscriptlon numbers In 2024 were 1,375.. 2023 totrl 1,866, 2022 total: 1,566, 2021 total.. 1,637. The Joumal continues to publlsh abstracts Sn French, Germon, Spanlsh. LAL has cOnnUed to fuTrJ grants In the fleld of Labwatory Animal Sdence, whlle offerirrfj a hvjh-quallty Joumal to our Subscribing A55cKhtM)n5 at a very favourable rate. The overall content and fomiat of the Joumol has remglned unchanged. The Journal accepted 79 artkle5 In 2024 Ind1r0 orlglnal atlcles, Revlew artlde5. Short Repts, Case Reports and Perspethve )rUcles. There were tsvo edilorlals, and four worklrrtJ party reports, these latter were., Guldance on the assessment of leamln9 outrornes lor those deslgnlng procedures and projects - Report of an Worklrwj Groupt Paln management In zebralish.. Report Irorn a FELASA WorkSng Grwp, FELASA Wothng GTOUP report.. Capture and tTrn5POrt of Ilve phalopods- recommendatlons lor sclentlllc purposes, Guidellnes for the establIshnt and functioning of Animal Etk*5 Committees Ilnstr(ullonal Animal Care and Use Cornmltteesl In Afrlca. The News, Notes and Cornments INNQ ttIOnS contlnued to attract materkl a5 reports from SubsulblThJ Assooatlorfj on conference5, and anTh)Urrnents ardir¥I future conferences, events, and publkatlons. One spedal 155ue wa5 published In Cktober entitled "Bhostats.rs Notes.. The Tlrne to Flrst decisi has fallen fram 67 to 31 day5 slnce 2021, whllst the Tlme to Flnal Dedyon lrtcreased from 47 days In 2023 to 59 day5. Tlme In producdon Increo5ed to 108 days In 2024 cornpared to 55 days In 2023 due to Issue5 In the Sa9e prCbJu0n w(ess. The five.year rc4llng Impact factor of the loumal was 2.3, an indicatyon of stable perfornre wlth an upward trend 12018.. 1.117; 2019.. 1.495. 2020.. 2.471,. 2022.. 2.908; 2023.. 2.5). In 2023 the method of calculatlng the lrnpatt factor than9ed, whlch may affecl current and future cc¥nporfsoTLS. The Edltorial Board conslsts of five edltors, of whom are members of the Com and serve as lialson beeen the Edilortol r and the Trustees, Including presentlng a rep(xt on the status of the Joufnal ar ECICOM meetsngs. The 55 5ectSon Edltors ILfjted, with a dlver5e Intemarional representsthln. LAL ha5 rnalntslned Its rc411ng yearty contract wlih the pub115her SAGE 2024. The Implicats'ons of MThJ io an Open Access publishing model have £onUnued to be discussed extensivety during 2024 by the EC and Com, wlth valuable input from tre LAJ Edf(orlal Board, but the mechanlsm by which thls Ss to be achieved has yet to te finallsed. Options Include both uslng profe551oro1 publishers and thpkn.ng a sew-publishiry platforrn. Gfven that OFen Access wlll result In LAL'S maln Income stream from LAJ $th)rIptIOns dwlndling and needing reacernent ty the Introduction of an Article PrrKesgng tharye {APQ, both EC and Com 4ree that thi5 process should Th)t be rushed. LAL h1 a stand at the intematlonal Fneeting of Understanding Anirnal Re5earth IUAA) in May at the University of waCk. In addition, LAL spOnred free reglstraty'on lor up to 50 ddegates at the ExFobioteri05 Laun Amerfca 2024 meetiro in Mexro, folbwing the SeSuL sponsoring of their 2023 event.
LABORATORY ANIMALS LIMITED (REGISTERED NUMBER: 00899518) REPORT OF THE TRusfEES FOR ThE YEAR ENDED 31 DECEMBER 2024 OBJECTniES AND AcrnirriES The L4L newsletter was Inltlated mid-2022 and is circulated by email to all Joumal subscrlter5 on the LAL datsbase. The Newetter publishes the Table of Contents for the current Issue of the Joumal, with the ability to cllck through to the Joumal dlrecuy from the NeWetter. In 2024 over 1200 sub5crfbers recetved the Newsletter, wlth an opening rate of round 36% and a dick-through rate of 36%, which is regarded as good for this type of markeb'rrfj. The numter to the webslte was 36,023 in 2022, 47,861 In 2023 and 16,991 In 2024. wSth 387,876, 162,470 and 32,156 p&Jes vlewed, respectively, usng the Cpanel dats platform. Google Anatytics was also used In 2024, and their different rnethodology gave I0r figures of 7,514 web5bte vlslts and 13,519 page& It is like that Google Anal will be used frorn now. More data Is avallable at: https.'Inoc*erStvdio.g¢le,Corn1ul0IfertIngI2Id7ddq4-2bso4274-97Itr9b27a2Sa9Is1pgeIp_lI66sozcd The webslte is constantty revlewed for content and accuracy. In Ilne wlth the planned move for the Joumal to Open Access, the strtU of the LAL webyts is undergolng a re, whKh 11 contr.nue into 2025. Instibjtional support was provlded several courses and sclentific meeungs, In European countrfes as well as Argenbna, BrdzII, Indla and Srf Lanka and Mexlco. In 2024, 15 grants were awanjed from 22 appllcallons, tctallin9 49,880 Euros, compared to 14 grants from 25 application5 in 2023. Grnnts aw•rded In 2024: Numb•r purp Country IndividuBII Instltutlonal Amount BA530 School for Earty Career Researchers on Sy5temaYc Reviews of Anlmal Stttdles Gold Open Access publlcatlon of Guithnce on the assessment of leaming outcome5 for thase designirvj procedure5 and projects- Report of n Worklng Group HSBLAS Sevedty Semlnars Funding open access CC.6Y pU1(ab.0 In LAJ of the FELAS4. EFAT WG report on"FELASA Worklng Group report.. Capture and trarwrt of Ie cephalopods- recomrnendatlons for sdentlflc purposes. 18th FKAME/UoN Trolnlw Schoc4 In ExperSrnental De%'gn & stastical Anal5 of osdence & Blomedlal Experlrnents Support for AISAL KXX Congre55 Ernpowerfng researchers & maxlmlzlng learnlng to Improve cultu of Care prac5 In Sr5 Lanka SECAL Sclents'nc meeting ESLAV-ECIAM-AAWAC cOnferen'QUalIty In Anlmal Gire and Facility Management. Certificate course In Laboratory Anlmal Scien Attend a course Animal Experimentstion.. Welfate, Leglslation art Ethkal Committees and Evaluation of Projects ESLAV-ECLAM Summer Sch1 2025 Masterfs certincate (Master in Laboral¢Jry Anlmal SCIen and Welfare) Second Hybrid conferen on the scien of Lab)ratory Anlmals in Lètln America. ExpoBioterios Ftybrid 2023 - XLKhlmllco- Mexco Tralnlng Cour for tACUCs members Nonyav InstY(ution?I É3,000 BA531 BelJum InstituonI1 ,740 BA533 BA534 Gree Italy InStitutnal Insytutbonal ,000 2,740 BA536 UK Instltudcfflal 5,850 BA537 &4538 Italy Srl Lanka InstituOr Instr(udonal 1,200 2,99Q BA539 BA541 Spaln Institutlonal Swltsertand Institutional É4,150 4,200 BA544 BA54S India Brazll Insts"tudonal Indlwdual 5,000 É2,000 BA546 BA547 switrIad Instiiuiional Aryentlna Indlvidual 5,000 1.000 BA548 Mexico Institub'onal 5,(KID BA551 gentlna Institutlonal 2,000
LABORATORY ANIMALS LllmED (REGISTERED NUMBER: IJ0899518) REPORT OF THE TRusfEES FOR TNE YEAR ENDED 31 DECEMBER 2024 OBJEcfivES AND ACTIVrnES Publ1¢ Benellt statement The charltys trustees confirm that they have ccfflpled wlth the duty in secticm 1715) of the tha1e5 Act 2011 to have regard to the Charfty Commloorns general guldance on puNic benefit, 'Charf(les and Putlic Benefiv. The thaiitable vurposes 01 Latxsratory Anlmals we set out In its constltubon and the objects indude 'the advancement of public education in LbatOry animal suertt, techndogy weware,. The trustees ensure that the objects are achieved through the fundlng of a range of iniuauves In the field of laboratory animals and the publkat)n of the Journal, "Laboratrry Animals" ACHIEVEMENTS A14D PERFORMANCE Charltable actlvltleg The extent of the CharitaFAe Payments made is detsled In Note 5 to the flMncW ststemen Investments undertaken by the dlrectar5 must salegLwrd the assets of the company and are In accordance v4Ith guldellne5 lald down by the charty cornmlssion. There are no 5rfic envlronmental or ethlcal objectNe5 tsken Into account. The Investrnenl p¢Jthlio Is Managed under an Investment Management Servlce Agreefflenr th Cotstts & Co and has an 5nveStnt profile for long term growth wlth medSum rfsks. Inve#rnents a revlewed annually by the trustees. As part or tNs reW we have consolldated cash 5avlng5 to Coutts to #reamllne management of our portfollo. FINANCIAL REVIEW ReMrve9 poIIcy The cornpony held reseNes ol £1,617,371 (2023.. £1.466,815) as at 31st tkcerrtr 2024. The prfnclpal fundirvJ urces of the company are the sales of the loumal and handbooks, revenue from advert15ers and Interest from Investrnents. The comp3ny has a pjllcy of holding reserve5 whlch are at least double the total resources expended In any one year 50 - The production costs of the journal could be Underttten as necessary - The cornpany's aCtfvit In XIort of longer-ierm charltable wolects coubj be 9JFPOrted If requlred. The dlrertors have agreed to revlew the cornpany'5 reserves pollcles on an ongolng ba51& Investment Portlollo The investment p(xifolio is managed under an Inve5trnent Management seCe agreement wlth Coutts & Co. The market value ol the portfc4io as per the report frorn Coutts dated 31st December 2024 was £1,428,612 agalnsL a market value of £1,252,950 as at 31st December 2023; reallsed gains during 2024 were £49,255 {2023.' realSsed losses of E6,003} and unreallsed galns for 2024 were £99,322 (2023: £108,554). The cornpanvs results for the year and Irs flnandal posStk)n at the end cl the year are fully dlsdosed in the attached flnanckil atements. The net Income lor the year, belore the unrealised Investment galn crf £99,32212023.' £IQ8,554) and the reali5ed investment galn of £49,25512023'. alised Investment105s 01 £6,003) was a galn of £1,979 (2023.. Ioss of £17,570). The dlrettors advlse that the overall surplus for the year of £150,556 12023.. £84,981) wll Increase the general fund at the end of the year and that the balarte of É1,617,371 11 te carried forward. Grants iotalllng £40,126 {2023'. £52,565) were made JUng the year. T* Memorandum and Artlcles of A59XKation oblige5 the ujmpany to all Its resources UJ the advancement of put4ic education in laboratory anlrnal Science, technobgy and welfare. The principal oblecbve5 of the company are to achleve these alm5 by publication of the journal, 'LafxJratory Anlmals., and by fvndlng a range d InltSatives In the fleld of laboratory anlmal scknce especlally locus&J on 'traln the trainer" iniljatives. The maln Sour of Iorne continues to come from the production of the journal, the success of thls putlication has enabled the ongoing commrtrnent to the fundlng of institutional and indmdual grnnts. STRiicfuRi GOVERNANCE AND MANAGEMENT Governlng document The company 15 governed by its Nemorandurn and Artliles of A5ScKlab incorpornted 2nd Narch 1967 and arrtnded 28th November 1969, 22nd June 1988, 14th lune 2004 and 25th JU 2022.
LABORATORY ANIMALS LIMITED {REGIsfERED NUMBER: 00899518) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 STRvcfuRE, GOVERN¥V4CE AND MANAGEMENT Dirertors and M•nagtment The affalrs of the company are regulated ty its Memorandum and deS cl Assoaation. A mernbEr of the company mt fir# be a member of a laboratory aM31 sclence aslatIOn which has been aF¢Yoved by fv d1ctors. The comp3nWs dSre¢tors are elected by the members at an annual general meetlrvJ and Serve on the CcKbncil of managerrt (Board of Directors). As the company Is a registered charlty, these dlrector5 also seNe as charrty trustee5. They re1ve Information on their reskhjnslkn'lits'es from the arfvlsory materfal avallabLe frc4n the Companles House and Charity Comrnission webstes twt the company has no lcY for glving formal trainiThJ to new tru5ttts. The EKecutfve Commlttee s elected by the Cwncil of Managernt ènd Is wponsitAe to the Counal of Managernent for the day-ttrday managerrtnt of the cornpany. The Councll d Mana9ement meet a year and the EXeCUVe Commtee hold forrnal etingS or tdeconferences at ast four a year. The dlrectors of the company are volunteers who are not pald for tha'r setvKe5 but are relrnbursed for travel and othtt out of pocket expen5e5. The management of the company necesytates artNitie5 which can tske a conslderatle amount of vclunteer's Me, particulatly for officers and dlrectors engaged on speclfic projects. However, profes&onal ¢e adminlsLraUon, bookkeepSng, publishlng, advertlslng management and webgte rnaIntenan and devdopment are funded on commercial ba5. RestM)n5bbllieS of Sage Publicatsons Ltd Iprevlou51y the Royal Soclety of Medidne Press Ltd) indude all aspects of prcductlon and d[strfbuc of the journal, c(rdInatIOn of the edlt¢rlal process and cc41ettion of subscriptlors. The ekcUM of dlrectors from approved laboratory animal Scien adab0n5 someumes resuts In dlrectc¢s haviw an ntere5t in aSOn5 or Instttution5 to whom grants are awarded. THIRD PARTY INDEMNITY PROVISION FOR DIREcfoRS There Is a thlrd party lThlemnlty provlslon In pla for the beneni d all dlrector5 of the ctynpany. REFERENCE AND ADMINISTRATIVE DETAILS Regl•t•red Company nuffir 00899518 (England and Wales) Reglstered Charlty number 261047 R•glst•r•d offlc• PalIon Vlew 19 New Road Brighton East Sussex BNI iey prtnclpal addr•ss PO Box 373 Eye Suffolk IP22 9BS
LABORATORY ANIMALS LIMtrED (REGisfERED 14UMBER: 00899518) REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 P Rooymans B Zevnik (rgned 2516124) L Antunes P Jltkof N Ezov C GIItrRrt J Gregory J GuIln J Helppi K >Pbee M Bernrd A Rltchle J Orellana S Wells I Blanco J L TreThda J B Prin5 T Buch lappolnted 2516124) P Rlederer [regned 6191241 M Rltskes-Hoitlnga Ire&gned 24171241 EWr M Wllklnson Company Secretsry C Giltert Audltor• Hart Fowler LLP Stslurory Aydltors Chartsed Accountsnts Pavllion Vlew 19 New Road Brlghton East Sussex BNI IEY B•nk•rs Coutts & Co 440 Strand London WC2R L srATEMENT OF TRUSTEES. RESPONSIBIUTIES The trustees (who are 41$0 the director5 of Laborntory Anlmals Llmited for the purposes of cornpary law) are reSp)nle for wepfjrlng the Rerx)rt of the Trustees and the financlal statements in accordance wlth applicable law and United Kingdom ACCOUnng Stsndards (Unrted ng0rn Generalty Accepted Accountlng pr*ce) Includiro Financlol ReporlThJ Stsndard 102 The Bnanoal Reportlng Standard applScat4e In the LIK and ReputAic of Ireland" Company law requlres the tru#ees to prepare flnancw statements for each flnanclal year whKh give a true and fair view of state of affalrs of the charftsble company and of the incomlw resources and applicaoon of resources, includlng the Income and expendure, cl the charitsble cpanY for that period. In preparing those flnancial stater[ts, the trustees are requlred to sdert suitable accouMng pollde5 and then appty them conslstentty; observe the methojs and principks in Chaty SORP,. ake ludgernents ond estlmates that are reascThble and prude prepare the financial st3ternents Dn the goir¥J concem bass unless Is Inappropriate to presume that the charliable cornpany will ConnUe in business.
LABORATORY ANIMALS LIMITED (REGIStERED NUMBER: 00899518) REPORT OF ThE TRUSTEES FOR THE YEAR ENDED 31 OECEMBER 1024 srATEMENT OFTRvsfEES' RESKNSIBIUTIES- continued The trustees are responsib for keeplng proper aQUAtIng reccds whlch thxlose with wsonable accurw at any tirne the finanaal p05ib.on of the thorltstrle cttmpary and to enae them to ensure that the financlal statements compty hth the CompanÈs Act 2006. They are also respIble fcf safe9uardlng the assets of the chailtable company and hence for tan9 rea>Jnable steps for the prevention and detecb'on of fraud and other Irregularlfje5. In so far as the truth are aware.. the Is no rdevant audit informalon d whlch the charitsble companvs audf(ors are unaware. and the trustees have tsken all stsps that they oUt to have taken to make themsefve5 awore of ary rethnt audit Information and to establish Ihat the audIt5 are aware of that infomwtkffl. Th15 port has en wepared In accordance wlth the speclal th51on5 d Part 15 of the CompBnles Act 2006 rekityng to small companles. Approved by order of the bjard IY trustees m 22nd August 2025 and slgned its behaw bv: K AppleLYe- Trustre
REPORT OF THE INDEPENDENT AUDoRs TO THE MEMBERS OF LABORATORY ANIMALS LIMITED (REGisfERED NUMBER: 00899518) Opinion We have the flnancial statements of Laboratory Anlmals LIM (the charltable COrnpan for the year ended 31 December 2024 which comprise the State[rrt of Flnancial Activf(ies, the Balance Sheet and notes to the financlal staternents, Indudlng a summary of slgnlfkart Cnng polt1. The financlal reporung framework that has applied in thelr preparation is app1Kab law and United Klnylom Accounting Standards {uned KI0M Genwalty ACpted AcCnting prath), Includlng Financkl Reportlng StsNlard 102 The hnandal Rewtiry Standard applcable in the UK and Republic of Ireland,. In our qjinlon Ihe financlal statement&. gfve a true and fair view of the stste of the charftable company's affairs as at 31 Decernber 2024 and of Its IrornIn9 reso¢Jrces and applicauon of resources, induditvJ Its Income and expentlitufe, for the year then ended. have been proper prepared in accordance with Unf(ed Klngdcyn General ACpted Accounting Practi, Indudlng Flnancial Reportlng Stsndard 102 The Financw Rryorbng Stsndard applicable in the UK and RepUtrA Ireland,; and have been prepared in acCOrdar with the requlrements of the Companies Att 2006. BJgiS tor oplnlon We COndted our audll In accordan th Internauonal Standards on Audltlng lu IISAS IUK)13nd apF4icable kiw. Our responsbilltles under those standard5 are further deScrid In the Auditors, respOnbIle5 for the audlt of the flnarKial ststements secbon of our rert We are Iep2Thdent of the charItab cornpany In accordance with the ethlc)I requirernents th)t a relevant to our audlt of the linanoal ststements in the UK, IndLKling the FRC'5 Ethical standard, and we have fulnlled our other ethical re5ponsit411tle5 In accordance wlth these requlrernents. We belleve that the audit edee have ottained is sumdent appropriate to wovtyje a bass fcff cAJr op11on. Concluslons r•latlnq to golng concem Ln audltlng the financlal statemcnt5, we have concluded that the trusteeg use of the gtslng cthicem bJ¥s of accountlng In the preparaUon ol the finawKI st)tsments Is approprfaie. Based on the work we have performed, we have not identined any materfal uncertaintie5 relatlng to events or coThJItns that, Indivldualty or collectlvely, moy ca# Ignfflcant doubt on the charltable company's 4blUty to continue as a golng concern for a Ferlo(l of at least ts¥elve months from when the flnonckil slatements are authorised for1sgJe. Our respOnbIlItIeS and the respons1bil1es cl the trustees %4Ath respert to gc4ng concern ore dexrfbed In the rdevant sedons of th15 report. Other inlormatlon The trusree5 are reSpOrblE for the other Infcrfmètbn. The othw 1nl0rma0n comprlses the Informabon InclLJed In the Annual Report, other than the fin•nclal statements and our fle)rt of the Independent Audltors tre0. Our oplnlon on the flnancial ststements does not cover the other Inforniatlon and, except to the extent OthIse eypllclty Aaied In our report, we do not expre55 any form of assurance cowluslon Ihewn. In Connecti( wlth (yjr èudll crf the flnanclal ststements, our responslblllty Is to read the other InforrnaJon and, In dng so, consider whether the other inf0mtiOn Is rnatrrially inmnlstent wlth the Ilnanclal ststement5 or our knedge Dbtalned In the audit or otherw15e appeaTS to be materlally mlsstate(J. If we Idenufy swch materlal InConstenc1es or apparent rnaterlal rnis5tsternents, we are requlred to determlne whether thi5 glves rtse to a material misstatement In the financial 5taternent5 themselves. Il, based on the work we Ikive rerftymed, we conclude thal Ure Ss B materlal mlsatennt of thls other Informatkjn, we are required to rekWJrt that fact. We have nothing tts report in thls regard. Oplnlons on other matters pmscrfbtd by the Companles Act 2006 In our opinion, b65ed on the work undertaken In the course of the audit.. the Infomiation glven in the Repjrt of the Trustees fcf rhe financlal year for whlch the finanual statements are prepared Is conslstent wSth the finanaal staternent5,' ond the RepKJrt of the Ttuthes has been prepared in accordan with appllcabte legal requlrements.
REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF LABORATORY ANIMALS LIMITED (REGISTERED NUMBER: 00899518) Matters on whSch we are required to report by exceptlon In the light of the knowle(SJe and urKJerandlng of the chaiitatAe company erOnnt obtained in the course of the alit, we have nrt idenufied materfal m6sstslents in the RerK)ri of the True& We the nothirfj to reFort in respect ol the fdlowlng matters where the Cunpanles Act 2006 requires u5 to repjrt to you if, in our opinlon.. 6de(wate accojntlng records have nct been kept or return5 adequate for our have not been received from branches not visited ty u5,. or the flnanclal Statements are not In agreement wlth the accountiThJ records and retwns. or rtain disclosures of trustees, remunerats.on specified by law are not rnade,. or we have not receNed all the irforrnab'on and eWanaVons we requlre for our audlt; or the trustees were nol entitled to take advantage of the small companies exemrknn from the requiremert to prepare a Strateglc Report ¢x In weparlng the Repc¥t ol the Twstees. Responslbllities of tru8teeJ A5 expL3lned more fully In the Staternent of Trustees, ReskKJnslbilities the trustees {who are alg) the dlrectCfj5 of the thaiitable company for the wrp05es of company law) are resp&ble for the preparauon cl the finandal 5taternents and fcf belng 5atisfieil that they glve a true and fair vlvrt, and lor Such llltemal control as the trustees deterrnlne Is necessary to enable the WeparatiC of financlal thternents that are free from rnaterlal mlsbtstement, whether due to fraud or error. In parIng the nnanclal statements, the trustee5 Jre respjndble for assessing the Charr(ab company's abllty to continue as a gcing concem, dlsd051ng, 05 appllcaL4e, matters related to g&ng concem and uslng the going concern baS of accounung unkss the trustees elther Intend to114uldaie the thorftstsle company or to cease operallons, or have no realistt alternotwe but lo do so.
REPORT OFTHE INDEPENDENT AUDrn)RSTOTHE MEMBERS OF LABORATORY ANIMALS LIMThED (REGIsfERED NUMBER: 00899518) Our responslbilltles for the audit of the financlal gtJtements Our objeckn.ves are to obtaln reanats1e 8S9jran aix)ut Whettr tkK financlal statements as a whole are free frorn material misstatemert, whether due to frnud error, and to Issue a Report d the Independent Audtor5 that Indudes our otynion. Reagjnable aSSurare Is a Ngh levd of assurance, Is not a guarantee that an audli cc¥¥Jucted In accordan with IS4s IUV will always detect a material misstatement when it exists. Misstatements can arise from fra or eThor and are consldered Material if, lndNidu61 or In the aggregate. they coubj reasonabty expected to Influence the ea)nomic decision5 of users taken on the basTs ol these financial ststemen Audit approach to idertifying and a95egslng Prt¢fttial risk5 related to irregularities Our pr(xedwes for Idenufying and a55e5slng risks of material misstaternent in resFett of irregLlarib'es, inc111j fraud and nOnMplIanCe wlth laws and regulatbons, Snduded the following.. Enqulrfrbj mènagement, Includlng oLkninlng and revlewlng wpp)rtlng dc(umertatlon,corKemlng the (MpanyS ptsllde5 and procedure5 relaung to: dentfyir¥J evaluang and ccrfnptylng With laws aTrJ regulaUon5 and whether they were oware d any Instances cl non-cornp1ian., - cktectlng and re5kKJndlw to the rlsks of fraud and whether they hwe knowledge of arry actual, suspected or alleged fraud,. and - the Sntemal controls establlshed to rnldgate rlsks related to fraud or nonfornrdrt laws and regulalons. - DISCUS amcry the enga9emnt team regardlng how and ¥kne fraud rnlght ¢XCUT In the flnancljl 5tsternents and any potenUal Indlcators of fraud. Obts5nlw an understandlng of the legal and regulatory frameworks that the company operates In, focuyng on those laws and regulatlons that had a direct effett on the flnanclal statemerts or thal had a fundamental effert on the operatlons of the company. The key wS and regulations we eCdere1 to have a dlrect effect on the financial statements Included the Finanaal Rep)rtlng Standard FRS 102 'Tre Flnanclal Reportlng appllcable In the UK aTh1 Repu1¢ of Ireland., char[e5 SORP IFRS 1021 'Accounts'ng and Reporting by Charities.. Ststemenl of Recornmended Practke and the Companies Act 2(K16 and we a55e5sed the extent of complIae wth these laws and regulatlons as part cl our procedures on the reLryd finanoal statement btems. The key laws and regulation5 we conthlwed to have h&a a fundamental effect the operadons of the company was the Chartries Art 2011. Audlt approach In ruponse to IdentKled rll Our procedures to re5p)nd to tlsks léentlfled Intded the following.. Inqulrlng of rnanement and, where approprfate, those char9ed with g0veman, as to whether the entlty 15 In complIan wf(h 5uth law5 and regulauons. - Inwung ccrespoThJence, 11 anyi wlth the relevant Ienrj crf regulatory authorftle5. - Revthlng the flnandal staternent dlsdosures and to 5UPWtlng documentaUon to assess cornpllan th reporung requirernents. Rev*wlng meetlng mlntrtes where avalhble for any Indlcatlon of non<ompl1an. In addressing the risk of fraud through managernent overrrde of contrd5, teSj the appropriateness of joumal entries and other ljustments,. a5%55ing whether the lu(Igements made In maklng accountsng estimates are Indicative of a potentkl blas,. and evalUan¢j the bune$S raOnale of any slgnbfKant transactions Ihal are unusual or out51dE the normal course of business. We also communicated relevant idenb'fied law5 and reguladons and potentlal fraud risks to all engagernenl tearn members and remalned alert to any indication5 of fraud lx non-compliance wilh law5 and regulations thrOUgUt audiL PerfDrmlng anaw'tal proiedures to klents.fy any unusual or unexpected relationships that fflay indlcate rlsks of rnaterlal misstatement due to fraud Through these prtxedures, we have not beccrfne aware of any actual crf suspected non-ccffnpl1nce. -iO-
REPORT OF THE INDEPENDE1 AUDThORS TO THE MEMBERS OF LABORATORY ANIMALS LIMITED (REGisfERED NUMBER: 00899518) O¥v6ng to the Inherent 11mOn5 of an there is an unavoidable risk that we not have deterted g)n materlal misstatements in the flnanckl stsments. Thls 15 parucutar for tho kws and regulatlons far removed frorn transacbon5 reflected in the financial ststemEnt& with any audY(, ttrre remained a hHJher risk of non-detettlon of irregubrities that result from fralvj, due to an ImF4Ied Intent behlnd thls, than from thr15e that result from error. As sraied in the audit standards, we are not responsi for preventirrtj noTrcompllan¢e and cannot te eywted to d&ecUcTrc0mplan wth all kws and regulati¢M5, A further de5crlkion of our s)nbIlItIeS for the audrt of the finanaal statements IKated on the Flnandal Repotlng Counal's webste al vMw.frc.¢yg.uklauditoryespor6ibilities. This de5cripb.on form5 part of our ReFKt of the IndeFondent Auditors. Use of wr weport This report is made solely to the charitsble compony's members, as a bryly, In attttldan with Chapter 3 of Part 16 of the Companles Att 2006. OUT aud work ha5 been undertaken 50 that we mlght state to the charltsble company's members those rnatter5 we are required to state to them In an audbtors, report for rKs other purpose. To the fLlles¢ extent perwnltted by law, we do not accept or asgjme responsibility to ane other than the tharitae Compary aThl the CharfIab companys members as a boty, for our audlt wrf¢, for th15 report or fcr the Onl¢ns we have fomied. Danlel Chaprnan {Senlor Statutory Audltorl f¢x and on behalf of H6rt1ry F(Mler LLP statutory Audll¢*s Chartered Accountants Pavillon Vlew 19 New Road 8rlghton Eart Sussex BNI IEY 2&......4....rf...2oir -li-
LABORATORY ANIMALS LIMrrED STATEMENT OF FINANCIAL AcrIvtrIES (INCORPORATING AN INCOME AND EXPENDrnIRE Accourir) FOR THE YEAR ENDED 31 DECEMBER 2024 2024 unrIcted fund 2023 Totsl lunds IP4COME AND ENDOWMENTS FROM Other trading aLtivbt In¥ethent Income 210,485 39,669 200,004 33,682 T¢)tsl 250,154 233,686 EXPENDMIRE ON Raising funds Other trddlw activSUe5 13S,977 139,742 135,977 139,742 Charltable Jctlvltle Grdnt5 PaYae Eyndlture on charftable athtS 40,126 64,504 52,565 52,151 Support Co*5 7,568 6,798 Trtal 248,175 251,256 Net galns on Inve#ments 148,577 102,SSI NEf 114COME 150,556 84,981 RECONCIUATION OF FUNDS Total funds brought forward 1,466,815 1.3BI,834 TOTAL FUNDS CARRIED FORWARD 1,617,371 1,466,815 The notes form of these finènaal statUTents -12-
LABORATORY ANIMALS LIMITED (REGISTERED NUMBER: 00899518) BALANCE SHEET 31 DECEMBER 2024 2024 Unrestricted fuTrJ 2023 Total funds FIXED ASSETS Investments li 1,428,612 1,252,950 CURRENT ASSErs 12 13 41 128,808 119,238 930 56,488 221,426 Debtors Cash at bank 248,087 278,8H CREDITORS Amounts falllng due wf(hln one year 14 159,328) (64,979) NEf CURRENT ASSErs 188,759 213,865 TOTAL ASSEfs LESS CURRENT LIABIUTIES 1.617,371 1,466,8lS NEf ASSErs 1,617,371 1,466,815 FUNDS Unrestricted fvnds 15 1,617.371 1,466,815 TOTAL FUNDS 1,617,371 1,466,815 These flnanclal statements have teen prepared In accDrdorKe wlth the ffiOn5 app4lcable to charltstle cornpanles Jbject tts the srnèll wmpanle5 rerne, The flnandal statements were approved by the e¢ard of Trustees and authorlsed for &sue 22nd Agust 2025 and were agned on Its behow by; K iipplebée . Tru The notu frym part of Ihe5e finaKlal ststets -L3-
LABORATORY ANIMALS LIMITED NOTES TO THE FINANCIAL sfATEMENTS FOR THE YEAR ENDED 31 DECEMBER 1024 ACCOUNTING POUCIES Basls of weparlng the flnbnclal staternents The financial atements of the chartae company, is a public benefit eYtity under FRS 102, have been prepared In accordance with tre Tharltles SORP IFRS 1021 'AccounknThJ aTrJ Reportlng by CharleS.. Stslement of Recommended Prathce appllcable to charitles preparlng their accounts in accordance wlth the Flnanclal Reporting Standard apICable in the UK and Republic of Ireland IFRS 1021 (effective I lanuary 20191,, and the Cornpanles Att 2006. flnanclal ststernents have been prepared under the hlstrical cost corNention as rnrxlhfled by the revaluation of certth'n assets, in partular fixed asset investments which are hdd at market value, The wesentstion currency is £ sterliw. Laknratory Anirnals Limited was IncLYporated In England and Wales, under the panIeS Act. The registered ctynpany number Is 00899518. Latrx)ratory Animals Llmrted 15 al a reglstered charfty ¥¥lth the Charlties Commlsslon, reglstered charity numter 261047. The trustees conslder that there are m)ierlal nrtaIne5 about the charty'5 abillty to contlnue as a goiThJ conrem due to the net ossel postlon. Incornlng resource5 All incoffle 15 recagnised In the Ststement ol FlnaKlal Acifvltle5 once the charfty has enljtlement to the lunds, It Is probat4e that the Income wlll be recaved and the anUt can be sured relIab. Income genera from journal subSCrfOS and the sale of handbjoks are reco9ni5ed, rt of VAT, when the Income and Fodod to whlch It relates has teen communlcated, In wdting by thc publisher. AdVertIn9 Irme Is retognised, net of VAT, when the Income and perlod to whlch It relates has teen communicated, In writlng by the seNlce provider. These staterrtnt5 ore received as a bi-mcnthty Income ent. Interest on fun(15 held on depjth Is Included upon nottncation of the Interest pald or payabje by the Bank. DldendS are recognlsed On the dlvklend has been declared and notlflcatian ha5 been recelved of the didend dL. Thls Is norrnalty upon notMCa0n ty the Investment ètfvlsor of the dlvldend e1 of the1nvestment prytrolS0, Lkbllitles are recognlsed as expendlture as soon as there Is a legal or constructive OlAatIon committlrv4 the charity to that expendlture, It K5 probatde that a transfer of economlc beneflts will be required In Settlement and the amount of the obligabon can be measured reliabty. ExFendlture Is accounted for on an accnjals baS and has been dassKd under headlngs that aggregate all cost related to the category. Where cost5 cannot be dlrecdy attrlbuted to partlcular headings they have been allocated to on a basls conslsient wlth the use of resources. Grants offered subjert to cOndIonS whlch have not been rnet at the year end date are noted as a ccmmitrnent but not accrued as expendIre. stocks stocks are valued at the lower of cost and net reallsaNe value, aftw makn'n4 due alkwjance for obsolete and sh rnoving liem5. Thxation The charity Is exempt Irom c¢ywraUon tsx on Its tharltatde actlvlves. Fund accountlng Unrestricted funds can be used in accordan wth the CharitRb obj'ectfves at the diKretion of the trLths. Restricted funds Ean On be used for particukir re5trtrted purposes within the objects of the charty. Restrfctions arfse when specffled by the donor or when funds are raised for p6rbtuLir restricted purp)ses. -1
LABORATORY ANIMALS LIMThED NOTES TO THE FINANCIAL sfATEMENTS- contlnued FOR THE YEAR ENDED 31 DECEMBER 2024 ACCOUIITING POUCIES- ¢ontlnued Foreign curnenciel Forelgn currency trOnstIonS a translabj InLo sterling at the rate5 of exchange rulSng at the dates on which the trartJn5 occur. AJI ftKsnetary assets and liabilities denomlnated In foreign CuenCieS are tranated Into sterllng at the rates exchange at the bn¢e Sheet date. Gains and losse5 ardng frcxn forelgn cunErKv tran4ations are tsken to the Staterrcnt of Flnancial AcbvItS (SOFA) for the year, Investrnents are measured at falr value. Falr value Is deemed to be the market price, reccJnlsed ftom the relevant strk nK7rkeL as at the yeat end. Revaluation5 are the reallsed and Ur}11$ed fnovernent of the Investments, market value. ReallsaNe galns and losses are recojnlsed C the Invesfftnts d15twil of dun9 the year, whlL5t unfeallsed gains and losses are recogn15ed on the Inve5trnents thot the chaty contlnues to hohj as al the year Debtors and cr•dltors r•c•lvable I payable wlthln one y•ar Debtors and credltors wlth no stated InteW rdte and reielvables or payable5 wlthln une year are corded at tsarrctiOn Prf. Any losses arlslng from ImpaSrmenl are recoJn15ed In the Ststement of Flnanoal Actie$ In chèriraLYe actl¥ADes. OThER TRADING ACTIVMES 2024 2023 SubscrIpon5 Pay per vlew and a94regators Sale of Handbooks Joumal advertjslng Onllne Llcenslng and Consorua 111,581 2,889 1,132 33,616 61,267 114,832 4,170 835 34,773 4S,394 210,485 200,004 INVEsfMENT INCOME 2024 2023 LIdends- UK irterest recelved - UK Fed 32,423 7,246 29,582 4,lQO 39,669 33,682 OThER TRADING ACllVITIES 2024 2023 Opening 5trKk Purchases CbJng stock Sage put4ishing costs Exhibition costs FOren ExchaThJe dirrerences 930 20.989 {41) 114,231 1,469 11,601) 94S 23,757 {9301 110,410 7,063 {1,5031 135,977 139,742 -15-
LABORATORY ANIMALS LIMITED NOTES TO THE FINANCIAL STATEMENTS- cantinued FOR THE YEAR ENDED 31 DECEMBER 2024 Grdnt fundSng of activibes (see note sUprt costs15ee note 7) 61 Totals Grants payab Expendtture on charltabk ac0vS 40,126 40,126 64,5a4 64,S04 40,126 64,504 104,630 fjRANTS PAYABLE 2024 2023 Grants payable 40,126 52,565 The tctsl grants pald to InstitutJoN8 durlng the year was as foibws., 2024 2023 (knnts Payable 37,603 52,565 The total grants pJld to Indlvlduab durfng the year was as fc41ows.' 2024 2023 Grants paYae 2,523 Grants io IntutI)n5 £ Grdnts to Indlvlduals É ActMtyIProJect Total £ Tralniryleducatlon 37,603 2,523 40,126 Tot 37,603 2,523 40,126 See the of the Trustees lor detalls of materlal grants to in<uUon& SUPPORT COSTS Governance ExpendMwe on charftae acuvltles 64,504 -16-
LABORATORY ANIMALS LIMrrED NOTES TO THE FINANCIAL STATEMErirs- continued FOR THE YEAR EMDEO 31 DECEMBER 2024 SUPPORT COSTS- contlnued Supwt costs, IKluded in the ab)ve, are as fdlows: Governance catts 2024 Expenditure on chadratr)te (titIeS 2023 Totsl actiwtie5 Audtors, remuneradon Auditors, remunerntlon for non oudlt work Meellng expenses Insurance Office expenses Proles90nal fees Seuetarknit fees 6,550 2,750 36,966 862 3,520 119 13,737 6,400 2,700 21,930 1,131 5,284 103 14,603 64,S04 52,151 NEf ENCOMEI(EXPENDITIJRE) Net Incomel(exwndJfure) Is stated after Charg1{Credlng).' 2024 2023 Audltors, reMUneraon Auditors, remuneratlon for non Judil bwrk 6,550 2,750 6,400 2,700 TRUSTEES, REMUIIERATION AP4D BENEFITS No tnJ5tees were remunerata by the company durlng the year. ring the year there were expenses of £7,50612023: £4,660) relrnbursed to 18 tru#ees12023.' 11) In reladon to thelr atteryjance ai meetlng 10. STAFF cosrs The avetage numter of emoYeeS duilng the year was Nll12023: NII). No ernployees recew emoIuThnts In exces5 of £60,0. -17-
LABORATORY ANIMALS LIMrrED NOTES TO THE FINANCIAL sfATEMENTS- continued FOR THE YEAR ENDED 31 DECEMBER 2024 11. FIXED ASSEf INVEsnolENTS iNestments MARKEf VALUE At l January 2024 AddOn5 Disposa Revaluabcns 1,252,950 1,185,194 11,108,854) 99,322 At 31 December 2024 1,428,612 NEf BOOK VALUE At 310erember 2024 1,428,612 At 31 December 2023 1,252,950 There were no Investment assets outde the UK. Cost or valuatkin at 31 December 2024 Is represented by.. Llsted Investrnents Valuats'on In 2024 Cost 184,871 1,243,741 1,428,612 11. srocKS 2024 2023 Stocks of Handbooks 41 930 13. DEBTORS: AMOUNTS FALLING DUE WIThIN ONE YEAR 2024 2023 Trade DeL*ors Prepayrnents and accrued Income 67,124 61,684 IlJ49 45,139 128,808 56,488 -18-
LABORATORY ANIMALS LIMITED NOTES TO THE FINANCIAL ATEMErS- continued FOR THE YEAR ENDEO 31 DECEMBER 2024 CREDITOR&. AMOUt4TS FALUNG DiIE wrrHIII ONE YEAR 2024 2023 19,336 10,938 8,351 16,568 4,135 6,161 8,390 32,279 16,416 1,733 VAT Grants payab Accrued exFenses ACcd grants payable 59,328 64,979 MOVEMENT IN FUNDS Net At 31112124 At 111124 In funds Unr•strfrt•d fund• General lund 1,466,815 150,556 1,617,371 TOTAL FUNDS 1,466,815 150,556 1,617.371 Net movement In funds, irKluded In the atrthie are as lollow5: Incomlng resour Re5wrces expend&l Galns and In fvnds Uniertrfct•d fundi General fL*)d 250,154 (248,1751 148,577 150,556 TOTAL FUNDS 250,154 {248,175) 148,577 150,556 Comparatlves for movefflent Ih fund• Net vement In funds 111123 31112123 Unrertfictsd fund• Generol fund 1,381,834 84,981 1,466,815 TOTAL FUNDS 1,381,834 84,981 1,466,815 coMparate net M0vennt In fund5, Induded In the above are as fe41ows.' Lncornlng sources Resources expended Galns and Movement in funds Unrestrlcted funds General fund 233,686 1251,2561 102,551 84,981 TOTAL FUNDS 233,686 (251,256) 102,551 84,981 -19-
LABORATORY ANIMALS UMThED NOTES TO THE FINANCIAL sfATEMENTS- continued FOR TH£ YEAR ENDED 31 oecEMBER 2024 MOVEMENT IN FUNDS- contlnued A current year 12 months and prfcrf year 12 months comblned MisItJ Is as follows.. nement in fd5 At 111123 31112124 Unrestricted fvnd¥ Gfftral fund 1,381,834 235,S37 1,617,371 TOTAL FUNDS 1.381,834 235,537 1,617,371 A current year 12 months and prior year 12 months comblned nel m(yIent in f¢Jnd5, IndLKJed in the JbD¥e are as follow5.' IncomiThJ Resc4Jr£es expended Gains and 1055es Movement In funds Unrestrlct•d fundj General fund 4B3,840 1499,4311 251,128 235,537 TOTAL FUNDS 483,840 1499,4311 251,128 235,537 RELATED PAKfY DISCLOSURES (Xher than trustees expenses detailed in note 9, there are no other related paty tran5actyon5 for the yur ended 31 Decernter 2024. 17. ULTIMATE COIIrnOLUNG PARTY The tru5tee5 conlder that there Is no ummate controlllng party. LTABILrrY OF MEMBERS The company is lirntsd by guarantee and does not have thare capitsl. In accordance wlth the company's Memwandum of Assocladon, In the event of the company beSng wound up, èll tmons who were members In the year prlor to the Company bang wound up are Ilable to contribute such ¢rt as may requlred to cover the costs arts]ng, up to a maxlrnum of £5 Fer memter. -20-
LABORATORY ANIMALS LIMITED DEfAILED STATEMENT OF FINANCIAL AcfiviTIES FOR THE YEAR EMDED 31 DECEMBER 2024 2024 2023 INCOME AND Et4DOWME14TS Other trathn9 Jrtivities Sub5crlpthJns Pay Fer Mew and aggrryator5 Sale of H3ndboc&s lournal advertising Online LicensiThJ and cOrt 111,581 2,889 1,132 33,616 61,267 114.832 4,170 835 34,773 45,394 210,485 2¢J),CMJ4 Invejtment Incornt Divldends- UK Interest reiVed - UK F 32,423 7,246 29,582 4,100 39,669 33,682 Total Incomlng r•MuruJ 250,154 233,686 EXPENDMIRE Other tradlng *ctl¥ltl•o Opening stock Joumal costs Advertlslng cornm1sOns and other thertlgng Sage pub115hlng costs Exhlbll1 ¢¢SLS FOren Exchange dlfferences a¢xlng slock 930 9,785 11,204 114,231 1,469 {1,6011 1411 945 12,168 11,589 110,410 7,063 (I,S031 19301 135,977 139,742 Charftsble actlvltle Grants to institution5 Grants to IndIdualS 37,6D3 2,523 52,565 40,126 52,565 Support Cgstl Portrc410 Management 7,568 6,798 GD¥•mance Ciffjts Audltc¢s' remunerats.on Audltors, remunerauC for nr audit work Meeting eyRnse5 Insurance Office exkEnses Profesgon31 fee5 Secretsriat fee5 6,550 2,750 36,966 862 3,520 119 13,737 6,400 2,700 21,930 1,131 5,284 103 14,603 64,504 52,151 Thi5 page does not fom t of the statutory finartw sratemenrs -21-
LABORATORY ANZMALS LIMrrED DEfAILED STATEMEt¥r OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2024 2024 2023 Totsl rex#Jr expended 248.175 251,256 Net Sncomel(expendlture) b•fore q•lAg and losses 1,979 117,570) Net 9ainsl(losses) on IDv¢stm•nts Nlt golnsl(hJsges) on InVestmts 14B,577 102,551 Net income 150,556 84,981 Thi5 pyg* t fomi part of Ihe stabJtory fflnanc stateDEnts -22-